rs9804200
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001375380.1(EBF3):c.636+2046G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.643 in 152,154 control chromosomes in the GnomAD database, including 31,676 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.64 ( 31676 hom., cov: 33)
Consequence
EBF3
NM_001375380.1 intron
NM_001375380.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.36
Publications
9 publications found
Genes affected
EBF3 (HGNC:19087): (EBF transcription factor 3) This gene encodes a member of the early B-cell factor (EBF) family of DNA binding transcription factors. EBF proteins are involved in B-cell differentiation, bone development and neurogenesis, and may also function as tumor suppressors. The encoded protein inhibits cell survival through the regulation of genes involved in cell cycle arrest and apoptosis, and aberrant methylation or deletion of this gene may play a role in multiple malignancies including glioblastoma multiforme and gastric carcinoma. [provided by RefSeq, Sep 2011]
EBF3 Gene-Disease associations (from GenCC):
- hypotonia, ataxia, and delayed development syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.686 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| EBF3 | NM_001375380.1 | c.636+2046G>A | intron_variant | Intron 7 of 16 | ENST00000440978.2 | NP_001362309.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.643 AC: 97740AN: 152036Hom.: 31664 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
97740
AN:
152036
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.643 AC: 97785AN: 152154Hom.: 31676 Cov.: 33 AF XY: 0.639 AC XY: 47558AN XY: 74378 show subpopulations
GnomAD4 genome
AF:
AC:
97785
AN:
152154
Hom.:
Cov.:
33
AF XY:
AC XY:
47558
AN XY:
74378
show subpopulations
African (AFR)
AF:
AC:
24282
AN:
41512
American (AMR)
AF:
AC:
9447
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
2604
AN:
3470
East Asian (EAS)
AF:
AC:
2462
AN:
5142
South Asian (SAS)
AF:
AC:
2584
AN:
4824
European-Finnish (FIN)
AF:
AC:
7186
AN:
10592
Middle Eastern (MID)
AF:
AC:
196
AN:
294
European-Non Finnish (NFE)
AF:
AC:
47013
AN:
68004
Other (OTH)
AF:
AC:
1374
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1840
3681
5521
7362
9202
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
788
1576
2364
3152
3940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1868
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.